v3.25.4
Investments (Tables)
12 Months Ended
Dec. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Equity Method Investments
Investments consist of the following (in thousands):

December 31,
20252024
Equity method - performance allocations$7,309,239 $5,958,079 
Equity method - capital interests (includes assets pledged of $521,124 and $647,448 as of December 31, 2025 and December 31, 2024, respectively)
1,801,436 1,284,255 
Loan held for sale— 47,880 
Investments held to maturity, at amortized cost (includes assets pledged of $82,198 and $73,485 as of December 31, 2025 and December 31, 2024, respectively)
88,480 78,941 
Investments held for sale and other(a)
— 121,995 
Equity method - other12,661 12,003 
Equity investments— 128 
Total investments$9,211,816 $7,503,281 
_________________
(a)As of December 31, 2024, investments held for sale and other includes $78.1 million of investments held for sale for which the fair value option has been elected.
The following table summarizes net gains (losses) from investment activities (in thousands):
Year Ended December 31,
202520242023
Net (losses) gains of investments held for sale and other$(2,227)$2,572 $— 
Net (losses) gains of equity method investments, fair value option— (26,785)15,264 
Net losses of equity method investments - other(838)(1,217)(1,306)
Net gains (losses) from equity investments218 (3,896)(7,394)
Total net (losses) gains from investment activities$(2,847)$(29,326)$6,564 
The following table shows summarized financial information relating to the Consolidated Statements of Financial Condition for all of TPG’s equity method investments assuming 100% ownership as of December 31, 2025 and 2024 (in thousands):

December 31,
20252024
Total assets$196,020,558 $153,574,291 
Total liabilities44,298,175 29,826,843 
Total equity151,722,383 123,747,448 
The following table shows summarized financial information relating to the Consolidated Statements of Operations for all of TPG’s equity method investments assuming 100% ownership for the years ended December 31, 2025, 2024 and 2023 (in thousands):
Year Ended December 31,
202520242023
Revenues$18,104,095 $13,639,080 $11,092,500 
Expenses4,442,523 4,379,772 4,134,838 
Net income$13,661,572 $9,259,308 $6,957,662 
Schedule of Equity Securities
Investments consist of the following (in thousands):

December 31,
20252024
Equity method - performance allocations$7,309,239 $5,958,079 
Equity method - capital interests (includes assets pledged of $521,124 and $647,448 as of December 31, 2025 and December 31, 2024, respectively)
1,801,436 1,284,255 
Loan held for sale— 47,880 
Investments held to maturity, at amortized cost (includes assets pledged of $82,198 and $73,485 as of December 31, 2025 and December 31, 2024, respectively)
88,480 78,941 
Investments held for sale and other(a)
— 121,995 
Equity method - other12,661 12,003 
Equity investments— 128 
Total investments$9,211,816 $7,503,281 
_________________
(a)As of December 31, 2024, investments held for sale and other includes $78.1 million of investments held for sale for which the fair value option has been elected.
The following table summarizes net gains (losses) from investment activities (in thousands):
Year Ended December 31,
202520242023
Net (losses) gains of investments held for sale and other$(2,227)$2,572 $— 
Net (losses) gains of equity method investments, fair value option— (26,785)15,264 
Net losses of equity method investments - other(838)(1,217)(1,306)
Net gains (losses) from equity investments218 (3,896)(7,394)
Total net (losses) gains from investment activities$(2,847)$(29,326)$6,564